166 related articles for article (PubMed ID: 15168341)
21. Evaluation of argyrophilic nucleolar organizer regions (AgNORs) in differentiated thyroid carcinoma as an indicator for disease recurrence.
Kawasaki F; Onoda N; Ishikawa T; Ogawa Y; Ikeda K; Sugano S; Kato Y; Chung KH
Oncol Rep; 2000; 7(4):853-7. PubMed ID: 10854557
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of the biological malignancy in hepatocellular carcinoma by argyrophilic nucleolar organizer region (AgNOR) staining--morphological study of AgNOR using image analyzer].
Shiro T; Seki T; Naitoh Y; Nakagawa T; Wakabayashi M; Itoh T; Shiozaki Y; Inoue K; Okamura A
Nihon Shokakibyo Gakkai Zasshi; 1994 Mar; 91(3):267-78. PubMed ID: 7908344
[TBL] [Abstract][Full Text] [Related]
23. Correlation between PCNA expression and AgNOR dots in pituitary adenomas.
Klencki M; Kurnatowska I; Słowińska-Klencka D; Lewiński A; Pawlikowski M
Endocr Pathol; 2001; 12(2):163-9. PubMed ID: 11579682
[TBL] [Abstract][Full Text] [Related]
24. Argyrophilic nucleolar organizer regions in colorectal malignancy: application of typing by their density.
Iwashita T; Mori H; Ito Y; Obashi A; Sugimoto K; Tei H; Hirata I; Oshiba S
Pathol Int; 1996 Mar; 46(3):204-10. PubMed ID: 10846571
[TBL] [Abstract][Full Text] [Related]
25. Thyroid follicular adenomas may display features of follicular carcinoma and follicular variant of papillary carcinoma.
Vasko VV; Gaudart J; Allasia C; Savchenko V; Di Cristofaro J; Saji M; Ringel MD; De Micco C
Eur J Endocrinol; 2004 Dec; 151(6):779-86. PubMed ID: 15588246
[TBL] [Abstract][Full Text] [Related]
26. Nucleolar organizer regions and PCNA expression in prostatic cancers.
Kawase N; Shiokawa A; Ota H; Saitoh T; Yoshida H; Kazama K
Pathol Int; 1994 Mar; 44(3):213-22. PubMed ID: 7517763
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of diagnostic efficiency of computerized image analysis based quantitative nuclear parameters in papillary and follicular thyroid tumors using paraffin-embedded tissue sections.
Gupta N; Sarkar C; Singh R; Karak AK
Pathol Oncol Res; 2001; 7(1):46-55. PubMed ID: 11349221
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic value of galectin-3 as a marker for malignancy in follicular patterned thyroid lesions.
Oestreicher-Kedem Y; Halpern M; Roizman P; Hardy B; Sulkes J; Feinmesser R; Stern Y
Head Neck; 2004 Nov; 26(11):960-6. PubMed ID: 15386597
[TBL] [Abstract][Full Text] [Related]
29. The value of PCNA and AgNOR staining in endoscopic biopsies of gastric mucosa.
Irazusta SP; Vassallo J; Magna LA; Metze K; Trevisan M
Pathol Res Pract; 1998; 194(1):33-9. PubMed ID: 9542745
[TBL] [Abstract][Full Text] [Related]
30. Ag-NOR counting for differentiation of follicular thyroid tumours.
Cör A; Pajer Z
Pathologica; 1994 Jun; 86(3):301-3. PubMed ID: 7808803
[TBL] [Abstract][Full Text] [Related]
31. Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid.
Máximo V; Preto A; Crespo A; Rocha AS; Machado JC; Soares P; Sobrinho-Simões M
BMC Cancer; 2004 Mar; 4():12. PubMed ID: 15043758
[TBL] [Abstract][Full Text] [Related]
32. Accumulation of p27(kip1) is associated with cyclin D3 overexpression in the oxyphilic (Hurthle cell) variant of follicular thyroid carcinoma.
Troncone G; Iaccarino A; Russo M; Palmieri EA; Volante M; Papotti M; Viglietto G; Palombini L
J Clin Pathol; 2007 Apr; 60(4):377-81. PubMed ID: 16798934
[TBL] [Abstract][Full Text] [Related]
33. [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses].
Teng XD; Wang LJ; Yao HT; Li J; Ding W; Yan LP
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):212-6. PubMed ID: 15256110
[TBL] [Abstract][Full Text] [Related]
34. Preoperative diagnosis of the follicular variant of papillary carcinoma of the thyroid: discrepancy between image and cytologic diagnoses.
Komatsu M; Hanamura N; Tsuchiya S; Seki T; Kuroda T
Radiat Med; 1994; 12(6):293-9. PubMed ID: 7724824
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the proliferation state in canine mammary tumors by the standardized AgNOR method with postfixation and immunohistologic detection of Ki-67 and PCNA.
Löhr CV; Teifke JP; Failing K; Weiss E
Vet Pathol; 1997 May; 34(3):212-21. PubMed ID: 9163877
[TBL] [Abstract][Full Text] [Related]
36. Morphometric determination of AgNORs in breast carcinoma. Correlation with flow cytometry and proliferating cell nuclear antigen.
Bellotti M; Elsner B; Kahn A; Bezodnick L; Pisilli L; Greco P
Anal Quant Cytol Histol; 1997 Apr; 19(2):139-44. PubMed ID: 9113306
[TBL] [Abstract][Full Text] [Related]
37. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
[TBL] [Abstract][Full Text] [Related]
38. Metastatic Follicular Thyroid Carcinoma and the Primary Thyroid Gross Examination: Institutional Review of Cases from 1990 to 2015.
Glomski K; Nosé V; Faquin WC; Sadow PM
Endocr Pathol; 2017 Jun; 28(2):177-185. PubMed ID: 28444500
[TBL] [Abstract][Full Text] [Related]
39. Proliferative activity of Hürthle cell thyroid tumours.
Cör A
Oncology; 1999 Jul; 57(1):17-22. PubMed ID: 10394120
[TBL] [Abstract][Full Text] [Related]
40. Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hupsilonrthle cell thyroid lesions: results from a series of 505 consecutive patients.
Rago T; Di Coscio G; Basolo F; Scutari M; Elisei R; Berti P; Miccoli P; Romani R; Faviana P; Pinchera A; Vitti P
Clin Endocrinol (Oxf); 2007 Jan; 66(1):13-20. PubMed ID: 17201796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]